Prestige Brands Holdings Inc (PBH):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Prestige Brands Holdings Inc (PBH) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9917
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:38
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Prestige Brands Holdings Inc (Prestige) focuses on the marketing, sales and distribution of over-the-counter (OTC) healthcare and household cleaning brands. The company offers its products for digestive care; lice treatment, household cleaning; hygiene; oral care; pain relief; pediatric care; skin care; eye care and women’s health, besides sleep aids and throat drops. It also offers antacids in Canada. The company commercializes its products through major retail channels, which include mass merchandisers, food, drug, dollar, club and convenience stores. It operates through subsidiaries in the US, Canada, and Australia and certain other international markets. Prestige is headquartered in Tarrytown, New York, the US.

Prestige Brands Holdings Inc (PBH) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Prestige Brands Holdings Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Prestige Brands Holdings Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Prestige Brands Holdings Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Prestige Brands Holdings Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Prestige Brands Holdings Inc, Medical Devices Deals, 2012 to YTD 2018 10
Prestige Brands Holdings Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Prestige Brands Holdings Inc, Pharmaceuticals & Healthcare, Deal Details 12
Asset Purchase 12
Prestige Brands Completes Acquisition Of Hydralyte From Hydration Pharma Trust 12
Prestige Brands Completes Acquisition Of 17 OTC Healthcare Brands From GlaxoSmithKline For US$660 Million 13
Equity Offering 16
Prestige Brands Holdings Announces Rights Offering Of Common Stock 16
Debt Offering 17
Prestige Brands Completes Private Placement Of Notes Due 2021 For US$400 Million 17
Prestige Brands Holdings Completes Private Placement Of Senior Notes Due 2020 For US$250 Million 18
Asset Transactions 19
Moberg Pharma Acquires DermoPlast from Prestige 19
Nutrition & Fitness Acquires Worldwide Rights to e.p.t from Prestige Brands Holdings 21
Moberg Pharma Acquires Three US OTC Brands from Prestige Brands for USD40 Million 22
WellSpring Pharma Acquires Bonine from Prestige Brands 24
Acquisition 25
Prestige Brands Acqiures Insight Pharma 25
Recordati Completes Acquisition Of Laboratorios Casen Fleet From C.B. Fleet For US$122.5 Million 27
Prestige Brands Acquires Care Pharma, OTC Healthcare Products Company 29
Prestige Brands Holdings Inc – Key Competitors 31
Prestige Brands Holdings Inc – Key Employees 32
Prestige Brands Holdings Inc – Locations And Subsidiaries 33
Head Office 33
Other Locations & Subsidiaries 33
Recent Developments 35
Financial Announcements 35
Feb 01, 2018: Prestige Brands Holdings Reports Fiscal 2018 Third Quarter Results 35
Appendix 38
Methodology 38
About GlobalData 38
Contact Us 38
Disclaimer 38

List of Tables
Prestige Brands Holdings Inc, Pharmaceuticals & Healthcare, Key Facts, 2018 2
Prestige Brands Holdings Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Prestige Brands Holdings Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Prestige Brands Holdings Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Prestige Brands Holdings Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Prestige Brands Holdings Inc, Medical Devices Deals, 2012 to YTD 2018 10
Prestige Brands Holdings Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Prestige Brands Completes Acquisition Of Hydralyte From Hydration Pharma Trust 12
Prestige Brands Completes Acquisition Of 17 OTC Healthcare Brands From GlaxoSmithKline For US$660 Million 13
Prestige Brands Holdings Announces Rights Offering Of Common Stock 16
Prestige Brands Completes Private Placement Of Notes Due 2021 For US$400 Million 17
Prestige Brands Holdings Completes Private Placement Of Senior Notes Due 2020 For US$250 Million 18
Moberg Pharma Acquires DermoPlast from Prestige 19
Nutrition & Fitness Acquires Worldwide Rights to e.p.t from Prestige Brands Holdings 21
Moberg Pharma Acquires Three US OTC Brands from Prestige Brands for USD40 Million 22
WellSpring Pharma Acquires Bonine from Prestige Brands 24
Prestige Brands Acqiures Insight Pharma 25
Recordati Completes Acquisition Of Laboratorios Casen Fleet From C.B. Fleet For US$122.5 Million 27
Prestige Brands Acquires Care Pharma, OTC Healthcare Products Company 29
Prestige Brands Holdings Inc, Key Competitors 31
Prestige Brands Holdings Inc, Key Employees 32
Prestige Brands Holdings Inc, Subsidiaries 33

List of Figures
Prestige Brands Holdings Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Prestige Brands Holdings Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Prestige Brands Holdings Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Prestige Brands Holdings Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Prestige Brands Holdings Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Prestige Brands Holdings Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Prestige Brands Holdings Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Prestige Brands Holdings Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Prestige Brands Holdings Inc, Medical Devices Deals, 2012 to YTD 2018 10

★海外企業調査レポート[Prestige Brands Holdings Inc (PBH):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • J.M. Huber Corporation:企業の戦略・SWOT・財務情報
    J.M. Huber Corporation - Strategy, SWOT and Corporate Finance Report Summary J.M. Huber Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Invenergy LLC:電力:M&Aディール及び事業提携情報
    Summary Invenergy LLC (Invenergy) is a full-service energy solutions provider. It invests, develops, constructs, owns, and operates renewable and other clean energy generation and storage facilities. The company captures, generates, and stores power from wind, solar, natural gas, and energy storage …
  • ORBIT Communication Systems Ltd:企業の戦略・SWOT・財務情報
    ORBIT Communication Systems Ltd - Strategy, SWOT and Corporate Finance Report Summary ORBIT Communication Systems Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Japan Airlines Co Ltd:戦略・SWOT・企業財務分析
    Japan Airlines Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Japan Airlines Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Encompass Health Corporation:企業の戦略・SWOT・財務情報
    Encompass Health Corporation - Strategy, SWOT and Corporate Finance Report Summary Encompass Health Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • NantKwest Inc (NK):製薬・医療:M&Aディール及び事業提携情報
    Summary NantKwest Inc (NantKwest), a subsidiary of NantWorks LLC, formerly Conkwest Inc, is a clinical-stage immunotherapy company that develops therapeutic treatments for cancer, infectious diseases, and inflammatory diseases. The company utilizes its immuno-oncology NK platform to destroy the tumo …
  • PTT Public Co Ltd (PTT)-石油・ガス分野:企業M&A・提携分析
    Summary PTT Public Company Limited (PTT) is an integrated national oil and gas, and petrochemical company. It operates in oil and natural gas, coal, power, and infrastructure businesses. The company carries out oil and natural gas exploration and production; oil refining; procurement, processing, tr …
  • United Rentals Inc:戦略・SWOT・企業財務分析
    United Rentals Inc - Strategy, SWOT and Corporate Finance Report Summary United Rentals Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Hermes Europe GmbH:企業の戦略的SWOT分析
    Hermes Europe GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • UGI Corporation:企業の戦略・SWOT・財務情報
    UGI Corporation - Strategy, SWOT and Corporate Finance Report Summary UGI Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Kadmon Holdings Inc (KDMN):製薬・医療:M&Aディール及び事業提携情報
    Summary Kadmon Holdings Inc (Kadmon) is an integrated biopharmaceutical company that discovers, develops and markets small molecules and biologics for autoimmune and fibrotic diseases, various types of cancer, and genetic diseases. The company’s pipeline encompasses investigational candidates for th …
  • Aesica Pharmaceuticals Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Aesica Pharmaceuticals Ltd (Aesica), a subsidiary of Consort Medical plc is a contract development and manufacturing organization (CDMO). It manufactures and develops generic active pharmaceutical ingredients (APIs) and finished dosage forms. Aesica’s services portfolio encompass pre-formula …
  • Lee Enterprises, Inc. (LEE):企業の財務・戦略的SWOT分析
    Lee Enterprises, Inc. (LEE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Lakeland Bancorp, Inc.:企業の戦略・SWOT・財務情報
    Lakeland Bancorp, Inc. - Strategy, SWOT and Corporate Finance Report Summary Lakeland Bancorp, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • BowLeven plc (BLVN):企業の財務・戦略的SWOT分析
    Summary BowLeven Plc (BowLeven) is an independent oil and gas exploration and production company. The company’s business activities include acquisition, exploration, and development of oil and gas properties. It holds equity interests in offshore and onshore exploration acreage in Cameroon and Gabon …
  • Novartis Institutes for BioMedical Research Inc-製薬・医療分野:企業M&A・提携分析
    Summary Novartis Institutes for BioMedical Research Inc (NIBR), a subsidiary of Novartis AG is a medical research institute that offers treatment research and development programs. The institute offers clinical research services in areas of immuno-oncology, oncology, neuroscience, cardiovascular and …
  • D4t4 Solutions Plc (ISL):企業の財務・戦略的SWOT分析
    Summary D4t4 Solutions Plc (D4t4), formerly IS Solutions Plc, is an information technology service provider company. The company provides services such as data collection, data management, data analytics, and data solutions. D4t4 offers analytics and reporting; enterprise content management, web and …
  • Public Broadcasting Service:企業の戦略・SWOT・財務情報
    Public Broadcasting Service - Strategy, SWOT and Corporate Finance Report Summary Public Broadcasting Service - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Jubilant Life Sciences Ltd (JUBILANT):製薬・医療:M&Aディール及び事業提携情報
    Summary Jubilant Life Sciences Ltd (Jubilant) is an integrated pharmaceutical and life sciences company that provides pharmaceuticals, life science ingredients and drug discovery solutions. The company’s product portfolio includes radiopharmaceuticals, allergy therapy products, active pharmaceutical …
  • Select Energy Services Inc (WTTR):企業の財務・戦略的SWOT分析
    Select Energy Services Inc (WTTR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆